Home » Medical American big bull stocks have 2 down limits!Shareholders cleared their positions and reduced their holdings, and the company shot up after executives resigned.

Medical American big bull stocks have 2 down limits!Shareholders cleared their positions and reduced their holdings, and the company shot up after executives resigned.

by admin

Original title: 2 lower limit of medical beauty big bull stocks!After shareholders liquidated and reduced their holdings and executives left their posts, the company took action


On June 8, Big Bull sharesLongzi sharesStop down again. As of the close, the company’s stock price was reported at 51.56 yuan per share, with a market value of 22.8 billion yuan. The company’s stock price fell by the limit for two consecutive days, and the accumulated market value has evaporated 5.4 billion yuan.

In the evening of the same day, the company took action to maintain stock price stability.Company AnnouncementThe actual controller’s father, Shen Bingyun, will provide at least 500 million yuan to helpLongzi sharesStrategic implementation of medical beauty business.

And just a few days ago,Longzi sharesreleaseannouncement, Shen Bingyun intends to reduce its holdings by liquidation, based on today’s closing price, it may be more than 1 billion yuan in cash.

  shareholderUnderweight,Executivesresignation

The market generally believes that the company’s share price has dropped its limit for two consecutive days,Shareholder reductionIt is not unrelated to the announcement of the resignation of senior executives.

Langzi shares announced on the evening of June 4 that it received the “Notice Letter on the Plan to Reduce the Shares of Langzi” from shareholder Shen Bingyun. Shen Bingyun intends to conduct centralized bidding transactions orbig dealThe reduction of the company’s shares held by him in other ways did not exceed 19,976,900 shares, accounting for 4.49% of the company’s total share capital. As of the announcement date, Shen Bingyun holds 19,976,900 shares of Langzi, with a shareholding ratio of 4.49%.

Shen Bingyun is the father of Shen Dongri, the controlling shareholder and actual controller of the company, and Shen Jinhua, the person acting in concert. The prospectus disclosed by the company in 2011 shows that Shen Bingyun was born in April 1942 and is currently nearly eighty years old. If calculated based on the closing price of Langzi shares today, Shen Bingyun may cash out more than 1 billion yuan.

See also  Parties - Rhein insists on firewall against the AfD

In response to the intention to reduce holdings, the company also gave an explanation that Shen Bingyun is already at a high age, and this reduction is due to his own living arrangements and asset planning needs. Although Shen Bingyun has not served in the company, he has always been concerned about the company’s long-term development, and is firmly optimistic about the company’s future development prospects, especially in the company’s medical beauty business.

Langzi shares announced on the evening of June 7 that the company’s board of directors recently received a resignation report from Pan Linyan, the company’s deputy general manager and general manager of the Langzi business unit. Due to personal reasons, Pan Linyan proposed to resign from the position of deputy general manager and general manager of the Longzi business department. After resignation, she will no longer hold any position in the company. According to the relevant provisions of the “Articles of Association”, Pan Linyan’s resignation report became effective when it was delivered to the board of directors.

  The company shot to maintain stock price stability

Faced with the continuous falling limit of the company’s stock price, the company announced on the evening of June 8 that in order to support the development of the company’s medical aesthetics business, combined with Shen Bingyun’s asset planning, Shen Bingyun agreed and promised that after the implementation of the reduction plan for the shares held by him, Shen Bingyun Through compliant channels and appropriate methods, the amount of no less than 500 million yuan will be used to assist the strategic implementation of the medical beauty business of Langzi.

Since its establishment in 2006, Longzi has focused on the field of mid-to-high-end women’s clothing. In 2016, it began to enter the medical beauty service business field. Since November last year, the company’s stock price has increased by 467.84%. On June 1, Langzi shares once touched a new high of 71.60 yuan per share, more than 10 times the lowest position in the past two years.

See also  Tractors, the protest arrives in the Vatican: letter to the Pope and the Ercolina cow

The 2020 annual report shows that the total revenue in 2020 will be 2.876 billion yuan, which goes to the motherNet profitFor 142 million yuan.

From a business perspective, the fashion women’s clothing business will still be the largest revenue in 2020, contributing 1.329 billion yuan in revenue, accounting for nearly 50%; the medical beauty business will achieve revenue of 814 million yuan, accounting for about 28%; the green baby and child business will be achieved Revenue of 733 million yuan, accounting for about 25%.

From the perspective of profit contribution, the medical beauty business achieved a net profit of 68,867,900 yuan attributable to the mother in the current period, accounting for 48%; in the same period, the women’s clothing business was only 29,387,700 yuan, accounting for 21%; as for the previous green baby and child business, The loss was about 1,902,300 yuan.

The medical beauty business has become the main source of profit for Longzi shares.

As of the end of 2020, through the three major medical beauty brands, Longzi has formed a three-dimensional development pattern of high-end (Milan Baiyu), technology (high life), and light medical beauty multi-store chain (crystal skin medical beauty). It has 20 medical beauty brands. Beauty institutions (including 1 shareholding and entrusted management institution), including 4 hospitals and 16 outpatient clinics or clinics, are mainly distributed in Chengdu, Xi’an, Chongqing, Shenzhen, Changsha, Baoji and Xianyang.

  Medical beauty concept stocks “reduction tide”

Since the beginning of this year, medical beauty stocks have entered a mode of skyrocketing. As long as the companies that are in contact have their stock prices soaring. Entering June, the rise of the medical aesthetics sector has slowed down, which may be related to the successive disclosure of reduction plans in medical aesthetics concept stocks.

See also  Unfulfilled desire to have children: What role does nutrition play? | > - Guide

According to incomplete statistics, in addition to Langzi shares, recently, 6 listed companies involved in the medical aesthetics business have issued announcements on reductions in their holdings.Huaxi BiologicalBlonde RabbiAoyuan MeiguHarbin SanlianHaohaishengke

  Harbin SanlianOn the evening of June 6, it was announced that Zhao Qingfu, the company’s director, deputy general manager, and secretary of the board of directors, planned to reduce the company’s holdings by no more than 312,500 shares through centralized bidding within 6 months after 15 trading days from the announcement of the share reduction plan. (Accounting for 0.0987% of the company’s total equity).

And on June 4,Huaxi BiologicalIt also issued an announcement stating that the company’s shareholder Yingrui Wuyuan plans to reduce its holdings of the company’s shares by a centralized bidding method at market prices to no more than 4.8 million shares, and the number of shares to be reduced shall not exceed 1 in the total share capital of the company. %.

Chuancai Securities believes that medical beauty, etc.themeThere has been a significant decline recently.In the long run, medical aesthetics and other directions are relatively good tracks, the industry space is large, the companyPerformanceGrowth blocks, so this type of sector has continued to strengthen before this, and many stocks have doubled in the short term. However, in the short term, there are certain risks in this category of subject matter. On the one hand, many companies in the industry have “hot spots”, and the proportion of related businesses is small, and they are labeled accordingly: On the other hand, some companies’ stock prices have risen in the short-term. Too fast, leading to a mismatch between valuation and performance, and then a fall.

(Source: China Securities Journal)

(Editor in charge: DF407)

Solemnly declare: The purpose of this information is to spread more information, and it has nothing to do with this stand.

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy